Dupilumab had a fivefold improvement in sustained disease remission in bullous pemphigoid compared with placebo, along with a significant reduction in oral corticosteroid use.

Dupilumab rapidly treated and maintained improvements in lichenification, a type of skin thickening from repetitive ...

Live webcasts for the events will also be accessible on Connect’s website in the Investors section under Presentations, Events & News at investors.connectbiopharm.com. An archived replay of the ...

Shenzhen Zhongge Biotechnology Co. Ltd. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to an interleukin-1 ...

In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients ...